Strontium was honored as "2023 China's Rising Stars".

Recently, the results of "2023 Deloitte China Hi-Tech High Growth 50 and Stars of Tomorrow" were announced. As one of the world's first platform synthetic biology companies to realize multi-substance mass production, Stripe Bio was selected as one of the "2023 China Stars of Tomorrow" by virtue of its biotechnology innovation capability and high growth potential.

Started in Silicon Valley in 1995 and introduced to China in 2005, the "Hi-Tech High Growth 50" program is held annually in more than 30 countries around the world, and is regarded as "the benchmark for global high-growth companies". The "Stars of Tomorrow" is its sister program, which aims to recognize outstanding companies that have been established for a short period of time, but are already leaders in their niche fields and have great potential. 

Stage Creative Bio is committed to platform development, technology-based, production-based, product breakthroughs, market-oriented, the first in the industry to realize the integration of research, production and marketing, the whole industry chain layout, sustainable development. We will always focus on meeting the new needs of the public for "medicine, food, beauty and security" with highly efficient, safe and environmentally friendly bio-manufacturing methods, and will join hands with partners in various fields to build a global synthetic bio-industry ecosystem.